Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Rai, Prashant ^a,b   He, Fang ^c   Kwang, Jimmy ^b,c   Engelward, Bevin P ^a,d   Chow, Vincent T K ^a,b  

^a SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BACTERIAL PROTEIN; DNA DEPENDENT PROTEIN KINASE; H2AFX PROTEIN, HUMAN; HISTONE; MDC1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; PRKDC PROTEIN, HUMAN; RECOMBINANT PROTEIN; STREPTOLYSIN; TP53BP1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR P53 BINDING PROTEIN 1;

A-549 CELL LINE; CELL CYCLE CHECKPOINT; CONFOCAL MICROSCOPY; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; STREPTOCOCCUS PNEUMONIAE; WESTERN BLOTTING;

A549 CELLS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA-ACTIVATED PROTEIN KINASE; HISTONES; HUMANS; MICROSCOPY, CONFOCAL; NUCLEAR PROTEINS; PHOSPHORYLATION; RECOMBINANT PROTEINS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR P53-BINDING PROTEIN 1;

EID: 84963657056     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22972     Document Type: Article

References (60)

1. Lucas, R. et al. Mini-review: novel therapeutic strategies to blunt actions of pneumolysin in the lungs. Toxins 5, 1244-1260 (2013).
2. Rodriguez, A. et al. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med 35, 430-438 (2009).
3. Waterer, G. W., Rello, J., Wunderink, R. G. Management of community-acquired pneumonia in adults. Am J Respir Crit Care Med 183, 157-164 (2011).
4. Paton, J. C., Andrew, P. W., Boulnois, G. J., Mitchell, T. J. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu Rev Microbiol 47, 89-115 (1993).
5. Guiral, S., Mitchell, T. J., Martin, B., Claverys, J. P. Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. Proc Natl Acad Sci USA 102, 8710-8715 (2005).
6. Spreer, A. et al. Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone. Antimicrob Agents Chemother 47, 2649-2654 (2003).
7. Orihuela, C. J., Gao, G. L., Francis, K. P., Yu, J., Tuomanen, E. I. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190, 1661-1669 (2004).
8. Canvin, J. R. et al. The Role of Pneumolysin and Autolysin in the Pathology of Pneumonia and Septicemia in Mice Infected with a Type-2 Pneumococcus. J Infect Dis 172, 119-123 (1995).
9. Schmeck, B. et al. Streptococcus pneumoniae-induced caspase 6-dependent apoptosis in lung epithelium. Infect Immun 72, 4940-4947 (2004).
10. Zysk, G. et al. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun 69, 845-852 (2001).
11. Braun, J. S. et al. Pneumococcal pneumolysin and H2O2 mediate brain cell apoptosis during meningitis. J Clin Invest 109, 19-27 (2002).
12. Tilley, S. J., Orlova, E. V., Gilbert, R. J., Andrew, P. W., Saibil, H. R. Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 121, 247-256 (2005).
13. Cassidy, S. K. B., O'Riordan, M. X. D. More Than a Pore: The Cellular Response to Cholesterol-Dependent Cytolysins. Toxins 5, 618-636 (2013).
14. Lim, J. H. et al. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27, 349-360 (2007).
15. Rubins, J. B. et al. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med 153, 1339-1346 (1996).
16. Witzenrath, M. et al. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Crit Care Med 34, 1947-1954 (2006).
17. Alhamdi, Y. et al. Circulating Pneumolysin Is a Potent Inducer of Cardiac Injury during Pneumococcal Infection. PLoS Pathog 11, e1004836 (2015).
18. Cockeran, R. et al. Proinflammatory interactions of pneumolysin with human neutrophils. J Infect Dis 183, 604-611 (2001).
19. Houldsworth, S., Andrew, P. W., Mitchell, T. J. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect Immun 62, 1501-1503 (1994).
20. Chumduri, C., Gurumurthy, R. K., Zadora, P. K., Mi, Y., Meyer, T. F. Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe 13, 746-758 (2013).
21. Li, N. et al. Influenza infection induces host DNA damage and dynamic DNA damage responses during tissue regeneration. Cell Mol Life Sci 72, 2973-2988 (2015).
22. Kaina, B. DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem Pharmacol 66, 1547-1554 (2003).
23. Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., Chen, D. J. ATM phosphorylates histone H2AX in response to DNA doublestrand breaks. J Biol Chem 276, 42462-42467 (2001).
24. Ward, I. M., Minn, K., Jorda, K. G., Chen, J. J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J Biol Chem 278, 19579-19582 (2003).
25. Panier, S., Boulton, S. J. Double-strand break repair: 53BP1 comes into focus. Nat Rev Mol Cell Biol 15, 7-18 (2014).
26. Christmann, M., Tomicic, M. T., Roos, W. P., Kaina, B. Mechanisms of human DNA repair: an update. Toxicology 193, 3-34 (2003).
27. Ciccia, A., Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol Cell 40, 179-204 (2010).
28. Dasika, G. K. et al. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 18, 7883-7899 (1999).
29. Hoeijmakers, J. H. J. Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374 (2001).
30. Walker, J. A., Allen, R. L., Falmagne, P., Johnson, M. K., Boulnois, G. J. Molecular-Cloning, Characterization, and Complete Nucleotide-Sequence of the Gene for Pneumolysin, the Sulfhydryl-Activated Toxin of Streptococcus-Pneumoniae. Infect Immun 55, 1184-1189 (1987).
31. Stucki, M. et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123, 1213-1226 (2005).
32. Stiff, T. et al. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 64, 2390-2396 (2004).
33. Riley, T., Sontag, E., Chen, P., Levine, A. Transcriptional control of human p53-regulated genes. Nature reviews. Mol Cell Biol 9, 402-412 (2008).
34. Zhang, X. P., Liu, F., Cheng, Z., Wang, W. Cell fate decision mediated by p53 pulses. Proc Natl Acad Sci USA 106, 12245-12250 (2009).
35. Chen, X. et al. DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control. BMC Biol 11, 73 (2013).
36. Abbas, T., Dutta, A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9, 400-414 (2009).
37. Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501 (1998).
38. Bartek, J., Lukas, J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 490, 117-122 (2001).
39. Kuzminov, A. Single-strand interruptions in replicating chromosomes cause double-strand breaks. Proc Natl Acad Sci USA 98, 8241-8246 (2001).
40. Stiff, T. et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J 25, 5775-5782 (2006).
41. van der Poll, T., Opal, S. M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374, 1543-1556 (2009).
42. Mandell, L. A. et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 Suppl 2, S27-72 (2007).
43. Anderson, R. et al. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother 60, 1155-1158 (2007).
44. Tessmer, A. et al. Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob Chemother 63, 1025-1033 (2009).
45. Gilbert, R. J. Inactivation and activity of cholesterol-dependent cytolysins: what structural studies tell us. Structure 13, 1097-1106 (2005).
46. Hamon, M. A. et al. Histone modifications induced by a family of bacterial toxins. Proc Natl Acad Sci USA 104, 13467-13472 (2007).
47. Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273, 5858-5868 (1998).
48. Iliev, A. I., Djannatian, J. R., Nau, R., Mitchell, T. J., Wouters, F. S. Cholesterol-dependent actin remodeling via RhoA and Rac1 activation by the Streptococcus pneumoniae toxin pneumolysin. Proc Natl Acad Sci USA 104, 2897-2902 (2007).
49. Stringaris, A. K., Bergmann, F., Geisenhainer, J., Bahr, M., Nau, R. Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase. Neurology 58, A262-A263 (2002).
50. Brookes, P. S., Yoon, Y. S., Robotham, J. L., Anders, M. W., Sheu, S. S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol-Cell Ph 287, C817-C833 (2004).
51. Wiseman, H., Halliwell, B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 313, 17-29 (1996).
52. Braun, J. S. et al. Pneumolysin causes neuronal cell death through mitochondrial damage. Infect Immun 75, 4245-4254 (2007).
53. Martner, A., Dahlgren, C., Paton, J. C., Wold, A. E. Pneumolysin released during Streptococcus pneumoniae autolysis is a potent activator of intracellular oxygen radical production in neutrophils. Infect Immun 76, 4079-4087 (2008).
54. Salas, V. M., Corcoran, G. B. Calcium-dependent DNA damage and adenosine 3',5'-cyclic monophosphate-independent glycogen phosphorylase activation in an in vitro model of acetaminophen-induced liver injury. Hepatology 25, 1432-1438 (1997).
55. Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64, 9152-9159 (2004).
56. Kracikova, M., Akiri, G., George, A., Sachidanandam, R., Aaronson, S. A. A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. Cell Death Differ 20, 576-588 (2013).
57. Lai, P. B. S., Chi, T. Y., Chen, G. G. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro. Apoptosis 12, 387-393 (2007).
58. Zheng, D. et al. Regeneration of alveolar type I and II cells from Scgb1a1-expressing cells following severe pulmonary damage induced by bleomycin and influenza. PloS One 7, e48451 (2012).
59. Rossjohn, J., Feil, S. C., McKinstry, W. J., Tweten, R. K., Parker, M. W. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 89, 685-692 (1997).
60. Price, K. E., Camilli, A. Pneumolysin localizes to the cell wall of Streptococcus pneumoniae. J Bacteriol 191, 2163-2168 (2009).